ClinicalTrials.gov
public full text
Public Domain
AT247, NovoRapid® and Fiasp® in Glucose Clamp Study
A Phase I, randomised, single-centre, double-blind, single-dose, three period, balanced cross over study in a glucose clamp setting. The study compares the pharmacodynamic, pharmacokinetic and safety characteristics of AT247, NovoRapid® and Fiasp® in male participants with type I diabetes mellitus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AT278 and NovoRapid® in Glucose Clamp Study#891245
- AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study#863364
- Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease#448232
- A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial#467536
- A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump#1095164
Record · ID 847129
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive